These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22228189)

  • 1. Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo.
    Roelofs AJ; Stewart CA; Sun S; Błażewska KM; Kashemirov BA; McKenna CE; Russell RG; Rogers MJ; Lundy MW; Ebetino FH; Coxon FP
    J Bone Miner Res; 2012 Apr; 27(4):835-47. PubMed ID: 22228189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo.
    Roelofs AJ; Coxon FP; Ebetino FH; Lundy MW; Henneman ZJ; Nancollas GH; Sun S; Blazewska KM; Bala JL; Kashemirov BA; Khalid AB; McKenna CE; Rogers MJ
    J Bone Miner Res; 2010 Mar; 25(3):606-16. PubMed ID: 20422624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.
    Iwata K; Li J; Follet H; Phipps RJ; Burr DB
    Bone; 2006 Nov; 39(5):1053-1058. PubMed ID: 16807159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.
    Bellido T; Plotkin LI
    Bone; 2011 Jul; 49(1):50-5. PubMed ID: 20727997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages.
    Roelofs AJ; Thompson K; Ebetino FH; Rogers MJ; Coxon FP
    Curr Pharm Des; 2010; 16(27):2950-60. PubMed ID: 20722616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing time-lapse micro-CT-correlated bisphosphonate binding kinetics and soft tissue-derived input functions to differentiate site-specific changes in bone metabolism in vivo.
    Tower RJ; Campbell GM; Müller M; Glüer CC; Tiwari S
    Bone; 2015 May; 74():171-81. PubMed ID: 25613175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding kinetics of a fluorescently labeled bisphosphonate as a tool for dynamic monitoring of bone mineral deposition in vivo.
    Tower RJ; Campbell GM; Müller M; Will O; Glüer CC; Tiwari S
    J Bone Miner Res; 2014 Sep; 29(9):1993-2003. PubMed ID: 24644087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate binding affinity affects drug distribution in both intracortical and trabecular bone of rabbits.
    Turek J; Ebetino FH; Lundy MW; Sun S; Kashemirov BA; McKenna CE; Gallant MA; Plotkin LI; Bellido T; Duan X; Triffitt JT; Russell RG; Burr DB; Allen MR
    Calcif Tissue Int; 2012 Mar; 90(3):202-10. PubMed ID: 22249525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
    Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.
    Plotkin LI; Bivi N; Bellido T
    Bone; 2011 Jul; 49(1):122-7. PubMed ID: 20736091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
    Coxon FP; Thompson K; Roelofs AJ; Ebetino FH; Rogers MJ
    Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.
    Li M; Healy DR; Li Y; Simmons HA; Su M; Jee WS; Shen VW; Thompson DD
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):22-32. PubMed ID: 15615075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between the chemistry and biological activity of the bisphosphonates.
    Ebetino FH; Hogan AM; Sun S; Tsoumpra MK; Duan X; Triffitt JT; Kwaasi AA; Dunford JE; Barnett BL; Oppermann U; Lundy MW; Boyde A; Kashemirov BA; McKenna CE; Russell RG
    Bone; 2011 Jul; 49(1):20-33. PubMed ID: 21497677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and antiresorptive properties of heterocycle-containing bisphosphonate analogs: structure-activity relationships.
    van Beek ER; Löwik CW; Ebetino FH; Papapoulos SE
    Bone; 1998 Nov; 23(5):437-42. PubMed ID: 9823450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
    Russell RG; Watts NB; Ebetino FH; Rogers MJ
    Osteoporos Int; 2008 Jun; 19(6):733-59. PubMed ID: 18214569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, OX14 (1-Fluoro-2-(Imidazo-[1,2-α]Pyridin-3-yl)-Ethyl-Bisphosphonate).
    Lawson MA; Ebetino FH; Mazur A; Chantry AD; Paton-Hough J; Evans HR; Lath D; Tsoumpra MK; Lundy MW; Dobson RL; Quijano M; Kwaasi AA; Dunford JE; Duan X; Triffitt JT; Jeans G; Russell RGG
    J Bone Miner Res; 2017 Sep; 32(9):1860-1869. PubMed ID: 28337806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength.
    Yao W; Cheng Z; Koester KJ; Ager JW; Balooch M; Pham A; Chefo S; Busse C; Ritchie RO; Lane NE
    Bone; 2007 Nov; 41(5):804-12. PubMed ID: 17825637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteocyte-directed bone demineralization along canaliculi.
    Nango N; Kubota S; Hasegawa T; Yashiro W; Momose A; Matsuo K
    Bone; 2016 Mar; 84():279-288. PubMed ID: 26709236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of oral osteomucosal tissue constructs in vitro and localization of fluorescently-labeled bisphosphonates to hard and soft tissue.
    Bae S; Sun S; Aghaloo T; Oh JE; McKenna CE; Kang MK; Shin KH; Tetradis S; Park NH; Kim RH
    Int J Mol Med; 2014 Aug; 34(2):559-63. PubMed ID: 24920042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.